MedPath

Can provision of ambulatory nutrition services to patients discharged from acute care improve health outcomes at an acceptable cost?

Not Applicable
Completed
Conditions
Malnutrition in Hospitalized patients
Diet and Nutrition - Other diet and nutrition disorders
Public Health - Health service research
Registration Number
ACTRN12614000833662
Lead Sponsor
Dr Yogesh Sharma
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
112
Inclusion Criteria

Patients admitted to general medicine ward aged sixty years or above, Ability to provide written consent or consent obtained from legal guardian if cognitively impaired, Identified as malnourished according to a standard malnutrition screening instrument-Malnutrition Universal Screening Tool (MUST).

Exclusion Criteria

Resides outside metropolitan Adelaide, Inability to obtain consent, non-english speaking, Aborigines, palliative patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in Patient Generated Subjective Global Assessment (PG-SGA) score.<br>[Baseline and at three months];European5 Quality of Life(EQ5D) Score[At baseline and then at three months];Hospital Re-admission rate<br>This will be determined by data linkage to patient medical records.[At three months as compared to control group]
Secondary Outcome Measures
NameTimeMethod
Cost-benefit analysis<br>The evaluation will be based on a primary outcome of cost per unit reduction in the PG-SGA( Patient generated Subjective Global Assessment) during the intervention period. That is, how much savings can be attributed to one unit of improvement in nutritional status. Utility-based outcomes will be incorporated into the analysis allowing a secondary outcome to be cost per QALY gained (based on the EQ5D level values). This will be determined using European Quality of Life Questionnaire(EQ5D) and Quality adjusted Life years(QALY) will be calculated.[At the end of three months as compared to control group.];Mortality[At three months as compared to control group.]
© Copyright 2025. All Rights Reserved by MedPath